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Behcet disease is the only primary vasculitis that affects
both arteries and veins of any size. We present our treat-
ment strategy in Behcet disease with vascular involvement
in seven childhood patients. All seven patietns met the
international criteria for the disease before the age of 16.
Only one was a girl. The vascular involvement was as fol-
lows: Two patients had superficial vein thrombosis, two
patients had atrial or ventricular thrombosis, two had
sinus vein thrombosis and one had arterial involvement
with pulmonary aneurysms.
The disease was diagnosed 4 months (range 3–24
months) before the vascular involvement in 4 patients
and concomitant with diagnosis in 3 patients. All received
colchicine, steroids and anticoagulant therapy. The ones
with thrombosis in the venous system recieved additional
azathioprine whereas those with pulmonary arterial or
cardiac involvement initially received cyclophosphamide
for 150–180 mg/kg total dose (IV or oral) and then were
switched to azathioprine for a further 6 months. These
patients have been followed up for period of 12 months
(ranging 4–30 months) and so far are free of vascular
relapses. One has developed a severe uveitis necessitating
further therapy.
In conclusion features of vascular involvement should be
carefully sought for in patietns with Behcet disease. Effec-
tive management is required for this feature of the disease
that has a high morbidity.
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